Method for modulating macrophage activation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/185 (2006.01) A61P 25/28 (2006.01) A61P 29/00 (2006.01)

Patent

CA 2320224

Anionic compounds, including sulfonates, are capable of blocking A.beta.- induced macrophage activation (or macrophage activation induced by other amyloidogenic proteins or peptides). Such compounds can inhibit the inflammatory process, e.g., in the brain of a subject suffering from a disease characterized by A.beta. deposition, such as Alzheimer's disease.

La présente invention concerne des composés anioniques, dont des sulfonates, capables de bloquer l'activation des macrophages induite par la protéine A beta (ou une activation des macrophages induite par d'autres protéines ou peptides amyloïdogéniques). Ces composés peuvent inhiber le processus inflammatoire, par exemple dans le cerveau d'un sujet souffrant d'une maladie caractérisée par un dépôt A beta telle la maladie d'Alzheimer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method for modulating macrophage activation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for modulating macrophage activation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for modulating macrophage activation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1815189

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.